With great power comes great responsibility

Medical Journal of Australia

Volumn 200, Issue 6, 2014, Pages 321-

  Bernal, Daniel D L ^a   Bereznicki, Luke R E ^a   Peterson, Gregory M ^a  

^a UNIVERSITY OF TASMANIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

AUSTRALIA; BEHAVIOR; CONFLICT OF INTEREST; EVIDENCE BASED MEDICINE; HUMAN; HYPERCHOLESTEROLEMIA; LETTER; TELEVISION;

AUSTRALIA; CONFLICT OF INTEREST; EVIDENCE-BASED MEDICINE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERCHOLESTEROLEMIA; POWER (PSYCHOLOGY); TELEVISION;

EID: 84904508334     PISSN: 0025729X     EISSN: 13265377     Source Type: Journal    
DOI: 10.5694/mja13.00061     Document Type: Letter

References (5)

1. Demasi M. Heart of the matter. The cholesterol myth: dietary villains and cholesterol drug war. Catalyst 2013; 24 and 31 Oct. http://www.abc. net.au/catalyst/heartofthematter (accessed Nov 2013).
2. Coleman J. Viewing Catalyst's cholesterol programs through the sceptometer. The Conversation 2013; 4 Nov. http://theconversation.com/viewing-catalysts-cholesterol-programs-through-the-sceptometer-19817 (accessed Nov 2013).
3. Carter AA, Gomes T, Camacho X, et al. Risk of incident diabetes among patients treated with statins: population based study. BMJ 2013; 346: f2610.
4. Ray KK, Cannon CP, Ganz P. Beyond lipid lowering: what have we learned about the benefits of statins from the acute coronary syndromes trials? Am J Cardiol 2006; 98 (11 Suppl 1): 18P-25P.
5. Ho PM, Spertus JA, Masoudi FA, et al. Impact of medication therapy discontinuation on mortality after myocardial infarction. Arch Intern Med2006; 166: 1842-1847.